Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

  • Immunostaining of Paraffin Sections

    Immunostaining of Paraffin Sections

    Procedure: 1) Fix tissues for 3 hr on ice in 4 formaldehyde (2.5 ml of Polysci

    2025-07-09 6
  • Immunostaining of Cells Adherent to Coverslips

    Immunostaining of Cells Adherent to Coverslips

    Immunostaining of Cells Adherent to Coverslips Procedure:1) Immerse 18 mm2 glass

    2025-07-09 6
  • Immunostaining Protocol

    Immunostaining Protocol

    Immunostaining Protocol (now with demo videos/stills)We recommend that you first

    2025-07-09 3
  • Immunosuppressive Mechanisms During Viral Infectious Diseases

    Immunosuppressive Mechanisms During Viral Infectious Diseases

    For a virus to establish persistence in the host, it has to exploit the host imm

    2025-07-09 4
  • Immunotherapy With CTL Restricted by Nonself MHC

    Immunotherapy With CTL Restricted by Nonself MHC

    In the past years a number of target antigens recognized by cytotoxic T-lymphocy

    2025-07-09 4
  • Immunotoxin Treatment of Brain Tumors

    Immunotoxin Treatment of Brain Tumors

    Current treatment for malignant gliomas, which includes surgery, radiation thera

    2025-07-09 4
  • Immunotube Selections

    Immunotube Selections

    Selection of phage-displayed antibodies on antigen-coated immunotubes is a fast

    2025-07-09 4
  • Implementing the Modular MHC Model for Predicting Peptide Binding

    Implementing the Modular MHC Model for Predicting Peptide Binding

    The challenge of predicting which peptide sequences bind to which major histocom

    2025-07-09 4
  • Improvement of Proteolytic Stability Through In Silico Engineering

    Improvement of Proteolytic Stability Through In Silico Engineering

    VHHs usually display high physical and proteolytic stability, but in some cases

    2025-07-09 4
  • Improvement of Single Domain Antibody Stability by Disulfide Bond Introduction

    Improvement of Single Domain Antibody Stability by Disulfide Bond Introduction

    The successful medical application of single domain antibodies largely depends o

    2025-07-09 5
  • Improving Antibody Binding Affinity and Specificity for Therapeutic Development

    Improving Antibody Binding Affinity and Specificity for Therapeutic Development

    Affinity maturation is an important part of the therapeutic antibody development

    2025-07-09 4
  • Improving Expression of scFv Fragments by Co-expression of Periplasmic Chaperones

    Improving Expression of scFv Fragments by Co-expression of Periplasmic Chaperones

    Today, recombinant protein expression in E. coli is usually considered a routine

    2025-07-09 4
  • Improving Phage Display Throughput by Using Hyperphage, Miniaturized Titration and pVIII (g8p) ELISA

    Improving Phage Display Throughput by Using Hyperphage, Miniaturized Titration and pVIII (g8p) ELISA

    Hyperphage is a substitute for M13KO7 helper phage used in antibody phage displa

    2025-07-09 4
  • Improving the Sensitivity of the ELISPOT Analyses of Antigen-Specific Cellular Immune Responses in R

    Improving the Sensitivity of the ELISPOT Analyses of Antigen-Specific Cellular Immune Responses in R

    The close similarities in hematopoietic and immune systems of humans and rhesus

    2025-07-09 4
  • In Silico De-Immunization

    In Silico De-Immunization

    This protocol shows how to reduce immunogenicity by removing CD4+ T cell epitope

    2025-07-09 4